FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

BACKGROUND: The survival status of patients with breast cancer and brain metastasis (BCBM) receiving current treatments is poor. METHOD: We designed a real-world study to investigate using patients’ clinical and genetic aberrations to forecast the prognoses of BCBM patients. We recruited 146 BCBM pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ning, Tian, Can, Wu, Hui, Yang, Xiaohong, liu, Liping, Li, Jing, Xiao, Huawu, Gao, Jianxiang, Lu, Jun, Hu, Xuming, Cao, Min, Shui, Zhengrong, Tang, Yu, Wang, Xiao, Yang, Jianbo, Hu, Zhe-Yu, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243401/
https://www.ncbi.nlm.nih.gov/pubmed/32499836
http://dx.doi.org/10.1177/1758835920915305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243401/
https://www.ncbi.nlm.nih.gov/pubmed/32499836
http://dx.doi.org/10.1177/1758835920915305

Ejemplares similares